The Impact of National Guidelines on Venom Immunotherapy Practice in the United Kingdom

Overview

Journal Clin Exp Allergy

Specialty Allergy & Immunology

Date 2016 Mar 19

PMID 26989871

Citations 5

Authors

L Diwakar

P Ewan

P A J Huber

A Clark

S Nasser

M T Krishna

Affiliations

Soon will be listed here.

Citing Articles

Skin prick tests are not useful for the qualification for venom immunotherapy in children.

Cichocka-Jarosz E, Brzyski P, Jedynak-Wasowicz U, Mol N, Klasa B, Mazurek-Durlak Z World Allergy Organ J. 2023; 16(5):100775.

PMID: 37351272 PMC: 10282561. DOI: 10.1016/j.waojou.2023.100775.

Current practices in diagnosis of Hymenoptera venom allergy in Poland.

Cichocka-Jarosz E, Brzyski P, Jedynak-Wasowicz U, Nittner-Marszalska M Postepy Dermatol Alergol. 2023; 38(2):222-229.

PMID: 36751544 PMC: 9880773. DOI: 10.5114/ada.2021.106200.

Cosmetic Applications of Bee Venom.

El-Wahed A, Khalifa S, Elashal M, Musharraf S, Saeed A, Khatib A Toxins (Basel). 2021; 13(11).

PMID: 34822594 PMC: 8625659. DOI: 10.3390/toxins13110810.

Antimicrobial Properties of 's Bee Venom.

El-Seedi H, Abd El-Wahed A, Yosri N, Musharraf S, Chen L, Moustafa M Toxins (Basel). 2020; 12(7).

PMID: 32664544 PMC: 7404974. DOI: 10.3390/toxins12070451.

Venom allergy treatment practices in Poland in comparison to guidelines: next edition of the national audit.

Cichocka-Jarosz E, Stobiecki M, Nittner-Marszalska M, Jedynak-Wasowicz U, Brzyski P Postepy Dermatol Alergol. 2019; 36(3):346-353.

PMID: 31333352 PMC: 6640023. DOI: 10.5114/ada.2019.85642.

References

Oude Elberink J, de Monchy J, Golden D, Brouwer J, Guyatt G, Dubois A . Development and validation of a health-related quality-of-life questionnaire in patients with yellow jacket allergy. J Allergy Clin Immunol. 2002; 109(1):162-70. DOI: 10.1067/mai.2002.120552. View

Diwakar L, Noorani S, Huissoon A, Frew A, Krishna M . Practice of venom immunotherapy in the United Kingdom: a national audit and review of literature. Clin Exp Allergy. 2008; 38(10):1651-8. DOI: 10.1111/j.1365-2222.2008.03044.x. View

Pitsios C, Demoly P, Bilo M, Gerth van Wijk R, Pfaar O, Sturm G . Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy. 2015; 70(8):897-909. DOI: 10.1111/all.12638. View

ONeill M, Karelas G, Feller D, Knudsen-Strong E, Lajeunesse D, Tsui D . The HIV Workforce in New York State: Does Patient Volume Correlate with Quality?. Clin Infect Dis. 2015; 61(12):1871-7. DOI: 10.1093/cid/civ719. View

Ware Jr J, Sherbourne C . The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992; 30(6):473-83. View

Prior M, Guerin M, Grimmer-Somers K . The effectiveness of clinical guideline implementation strategies--a synthesis of systematic review findings. J Eval Clin Pract. 2008; 14(5):888-97. DOI: 10.1111/j.1365-2753.2008.01014.x. View

Boyle R, Elremeli M, Hockenhull J, Cherry M, Bulsara M, Daniels M . Venom immunotherapy for preventing allergic reactions to insect stings. Cochrane Database Syst Rev. 2012; 10:CD008838. PMC: 8734599. DOI: 10.1002/14651858.CD008838.pub2. View

Hockenhull J, Elremeli M, Cherry M, Mahon J, Lai M, Darroch J . A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy. Health Technol Assess. 2012; 16(12):III-IV, 1-110. PMC: 4781549. DOI: 10.3310/hta16120. View

Grimshaw J, Thomas R, MacLennan G, Fraser C, Ramsay C, Vale L . Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess. 2004; 8(6):iii-iv, 1-72. DOI: 10.3310/hta8060. View

10.

Sheldon T, Cullum N, Dawson D, Lankshear A, Lowson K, Watt I . What's the evidence that NICE guidance has been implemented? Results from a national evaluation using time series analysis, audit of patients' notes, and interviews. BMJ. 2004; 329(7473):999. PMC: 524545. DOI: 10.1136/bmj.329.7473.999. View

11.

Krishna M, Ewan P, Diwakar L, Durham S, Frew A, Leech S . Diagnosis and management of hymenoptera venom allergy: British Society for Allergy and Clinical Immunology (BSACI) guidelines. Clin Exp Allergy. 2011; 41(9):1201-20. DOI: 10.1111/j.1365-2222.2011.03788.x. View

12.

Richter A, Nasser S, Krishna M . A UK national survey of investigations for beta-lactam hypersensitivity - heterogeneity in practice and a need for national guidelines - on behalf of British Society for Allergy and Clinical Immunology (BSACI). Clin Exp Allergy. 2013; 43(8):941-9. DOI: 10.1111/cea.12134. View